CHAMPION-AF

Atrial Fibrillation

WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation

Key Team Members

Principal Investigator

Robert A. Leonardi, MD, FACC, FSCAI

Research Coordinator

Stephanie "Quinn" Cirillo

Not Accepting Patients

About the Trial

The purpose of this study is to determine if LAA closure with the WATCHMAN FLXTM Device is a reasonable alternative to oral anticoagulation therapy (blood thinner medication).

Get Primary Care

Photo of the Lexington Medical Center hospital campus

Lexington Medical Center

2720 Sunset Blvd.
West Columbia, SC 29169
Google Maps

Hospital Map

Emergency Room

Find More Locations